Relationship Between Smad4-independent Pathway of TGF-β1 and Drug-Resistance of Pancreatic Cancer Cell Line

CHEN Ying,ZHAO Hai-hua,LI Fang-mei,YU Guan-zhen,ZHU Ming-hua
DOI: https://doi.org/10.3321/j.issn:0258-879x.2005.10.006
2005-01-01
Abstract:Objective: To investigate the relationship between the Smad4-independent pathway of TGF-β1 and drug-resistance of pancreatic cancer. Methods: The sensitivities of Smad4 homozygous-deleted pancreatic cancer cell line BxPC3 to different kinds of anti-cancer drugs (5-Fu, Gemzar, Oxaliplatin, Cisplatin, CPT-11 and Epirubicin) were observed by MTT assay before and after they were transfected with full-length cDNA of TGF-β1 or treated with TGF-β1 (5 and 10 ng/ml) solution. Western blot was used to detect p170 protein expression after stimulation with different concentrations of TGF-β1. Results: Cisplatin had the most powerful killing effect on BxPC3 cells, followed by Oxaliplatin, 5-Fu and CPT-11 with moderate effect and Gemzar and Epirubicin with the least effect. Cells transfected with full-length cDNA of TGF-β1 or treated with TGF-β1 solution became less sensitive to Cisplatin. Western blot revealed upregulation of p170 expression by TGF-β1. Conclusion: The Smad4-independent pathway of TGF-β1 can increase the drug resistance of pancreatic cancer cells through upregulating expression of p170.
What problem does this paper attempt to address?